Cargando…
B-cell lymphoma 6 alleviates nonalcoholic fatty liver disease in mice through suppression of fatty acid transporter CD36
Nonalcoholic fatty liver disease (NAFLD) is an ubiquitous disease that exists across a wide spectrum ranging from steatosis, steatohepatitis, advanced fibrosis, and liver cirrhosis. Hallmarks of NAFLD are lipid accumulation, insulin resistance, and chronic low-grade inflammation. However, there curr...
Autores principales: | Zhang, Hao, Li, Yue, Zhang, Chao, Huang, Kun, Zhao, Jing, Le, Sheng, Jiang, Lang, Liu, Hao, Yang, Peiwen, Xiao, Xiaoyue, Yu, Jizhang, Wu, Jie, Ye, Ping, Xia, Jiahong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016081/ https://www.ncbi.nlm.nih.gov/pubmed/35436984 http://dx.doi.org/10.1038/s41419-022-04812-x |
Ejemplares similares
-
Biological Mechanisms and Related Natural Inhibitors of CD36 in Nonalcoholic Fatty Liver
por: Feng, Yanan, et al.
Publicado: (2022) -
PLK1 Inhibition alleviates transplant-associated obliterative bronchiolitis by suppressing myofibroblast differentiation
por: Yu, Jizhang, et al.
Publicado: (2020) -
Fatty Acid Transporter CD36 Mediates Hypothalamic Effect of Fatty Acids on Food Intake in Rats
por: Moullé, Valentine S., et al.
Publicado: (2013) -
Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease
por: Sheedfar, Fareeba, et al.
Publicado: (2014) -
Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux
por: Liu, Cong, et al.
Publicado: (2018)